Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
240.28(c) 238.37(c) 241.51(c) 246.82(c) 248.85(c) Last
317 997 309 829 750 977 534 824 567 322 Volume
-0.81% -0.79% +1.32% +2.20% +0.82% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 13 675 M - -
Net income 2021 806 M - -
Net Debt 2021 10 224 M - -
P/E ratio 2021 60,0x
Yield 2021 -
Sales 2022 14 828 M - -
Net income 2022 1 063 M - -
Net Debt 2022 9 311 M - -
P/E ratio 2022 45,0x
Yield 2022 -
Capitalization 47 683 M 47 683 M -
EV / Sales 2021 4,23x
EV / Sales 2022 3,84x
Nbr of Employees 74 000
Free-Float 74,2%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
More about the company
Ratings of IQVIA Holdings Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about IQVIA HOLDINGS INC.
10/15Today on Wall Street: Optimism returns
10/15ANALYST RECOMMENDATIONS : BP, Domino's Pizza, Moderna, Tesla, US Bancorp...
10/15IQVIA : KeyBanc Lifts Price Target on IQVIA Holdings to $270 from $260, Keeps Overweight R..
MT
10/12IQVIA : to Announce Third-Quarter 2021 Results on October 21, 2021
BU
10/07IQVIA : to Host Financial Analyst and Investor Conference on November 16, 2021
BU
10/06IQVIA : Unveils North Carolina Lab Facility For Q2 Solutions Subsidiary
MT
10/06IQVIA : Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, C..
BU
10/06IQVIA Announces Opening of New Q▓ Solutions Innovation Laboratories in North Carolina, ..
CI
09/30IQVIA : Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Sal..
BU
09/30Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesfor..
CI
09/30PRESS RELEASE : Basilea's partner Asahi Kasei Pharma filed New Drug Application for the ma..
DJ
09/17ANI PHARMACEUTICALS : Launches Generic Hypertension Drug
MT
09/13NRX PHARMACEUTICALS : IQVIA to Provide Pharmacovigilance Services for NRx's COVID-19 Treat..
MT
09/13IQVIA : and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-1..
BU
09/10IQVIA : Argus Research Adjusts IQVIA Holdings' Price Target to $290 from $260, Keeps Buy R..
MT
More news
News in other languages on IQVIA HOLDINGS INC.
10/06IQVIA Holdings inaugure un laboratoire en Caroline du Nord pour sa filiale Q2 Solutions..
09/30GlobeNewswire/Basileas Partner Asahi Kasei Pharma reicht Antrag auf Marktzulassung (NDA..
09/13IQVIA fournira des services de pharmacovigilance pour le traitement candidat COVID-19 d..
08/17GlobeNewswire/Basilea meldet starke -3-
07/26GlobeNewswire/Basierend auf positiven Phase-3-Ergebnissen bereitet Basileas Partner Asa..
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | IQV | US46266C1053 | MarketScreener
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 248,85 $
Average target price 278,35 $
Spread / Average Target 11,9%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.38.89%47 683
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414
ALNYLAM PHARMACEUTICALS, INC.60.47%24 787